Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
These 2 moon rovers used cameras and lasers to hunt for simulated water ice — and one looks like WALL-E - 2The Manual for Electric Vehicles that will be hot dealers in 2023
- 3Moon fever hits DC as Artemis 2 rocket 'candle' lights up Washington Monument just 1 month before launch (photos)
- 4Russia Creates New Military Branch Dedicated To Drone Warfare
- 5Governors Ball 2026: Lorde, A$AP Rocky and Stray Kids set to headline
- Italian police hold suspected boss of Naples Mafia's Mazzarella Clan
- Czech Republic's new premier: No money for Ukraine
- Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
- Arctic sea ice just dropped to an alarming new low
- 5 Bike Brands for Ordinary Use
- Here's what can happen if you drive under the influence of pot
- Ukrainian man arrested in Germany on suspicion of spying for Russia
- Eight arrested in joint Scotland and Spain gang raids
- Tech for Wellbeing: Applications and Devices for a Better You
